Disclosures for "Incidence and Outcome of Neurologic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma"
-
Mr. Pepys has nothing to disclose.
-
Dr. Stoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pangea Biomed. Dr. Stoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Stoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MSD. Dr. Stoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. Dr. Stoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
-
Dr. Ramon-Gonen has nothing to disclose.
-
Dr. Ben Betzalel has nothing to disclose.
-
Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda . Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Dr. Dori has received research support from Biogen. The institution of Dr. Dori has received research support from Pfizer. The institution of Dr. Dori has received research support from Alnylam therapeutics. Dr. Dori has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Shelly has nothing to disclose.